1) Pasternak GW and Pan YX. Mu opioids and their
receptors: evolution of a concept. Pharmacol. Rev.
)2013( 65: 1257-317.
2) Martell BA, O’connor PG, Kerns RD, Becker WC,
Morales KH, Kosten TR and Fiellin DA. Systematic
review: opioid treatment for chronic back pain:
prevalence, efficacy, and association with addiction.
Ann. Intern. Med. (2007) 146: 116-27.
3) Kosten TR and O’connor PG. Management of drug
and alcohol withdrawal. New Engl. J. Med. (2003)
4) Blevins CE, Abrantes AM, Kurth ME, Gordon
AL and Stein MD. Quality of life and well-being
Curcumin Effect on Morphine Dependence in Rats
following inpatient and partial hospitalization
treatment for opioid use disorder. Arch. Psychiatr.
Nurs. (2018) 32: 505-9.
5) Matthes HW, Maldonado R, Simonin F, Valverde O,
Slowe S, Kitchen I, Befort K, Dierich A, Le Meur M,
Dollé P and Tzavara E. Loss of morphine-induced
analgesia, reward effect and withdrawal symptoms
in mice lacking the µ-opioid-receptor gene. Nature
(1996) 383: 819-23.
6) Liu WT, Han Y, Liu YP, Song AA, Barnes B
and Song XJ. Spinal matrix metalloproteinase-9
contributes to physical dependence on morphine in
mice. J. Neurosci. (2010) 30: 7613-23.
7) Mansour A, Fox CA, Akil H and Watson SJ.
Opioid-receptor mRNA expression in the rat CNS:
anatomical and functional implications. Trends
Neurosci. (1995) 18: 22-9.
8) Corder G, Tawfik VL, Wang D, Sypek EI, Low SA,
Dickinson JR, Sotoudeh C, Clark JD, Barres BA,
Bohlen CJ and Scherrer G. Loss of μ opioid receptor
signaling in nociceptors, but not microglia, abrogates
morphine tolerance without disrupting analgesia.
Nat. Med. (2017) 23: 164-73.
9) Hutchinson MR, Bland ST, Johnson KW, Rice
KC, Maier SF and Watkins LR. Opioid-induced
glial activation: mechanisms of activation and
implications for opioid analgesia, dependence, and
reward. Sci. World J. (2007) 7: 98-111.
10) Mattioli TA, Leduc-Pessah H, Skelhorne-Gross G,
Nicol CJ, Milne B, Trang T and Cahill CM. Toll-like
receptor 4 mutant and null mice retain morphineinduced tolerance, hyperalgesia, and physical
dependence. PloS One. (2014) 13: e97361.
11) Raghavendra V, Rutkowski MD and DeLeo JA. The
role of spinal neuroimmune activation in morphine
tolerance/hyperalgesia in neuropathic and shamoperated rats. J. Neurosci. (2002) 22: 9980-9.
12) Raghavendra V, Tanga FY and DeLeo JA.
Attenuation of morphine tolerance, withdrawalinduced hyperalgesia, and associated spinal
inflammatory immune responses by propentofylline
in rats. Neuropsychopharmacology (2004) 29: 327-
13) Chao CC, Gekker G, Sheng WS, Hu S, Tsang M
and Peterson PK. Priming effect of morphine on
the production of tumor necrosis factor-alpha by
microglia: implications in respiratory burst activity
and human immunodeficiency virus-1 expression. J.
Pharmacol. Exp. Ther. (1994) 269: 198-203.
14) Liu L, Coller JK, Watkins LR, Somogyi AA and
Hutchinson MR. Naloxone-precipitated morphine
withdrawal behavior and brain IL-1β expression:
comparison of different mouse strains. Brain Behav.
Immun. (2011) 25: 1223-32.
15) Hosseinzadeh H, Parvardeh S, Masoudi A, Moghimi
M and Mahboobifard F. Attenuation of morphine
tolerance and dependence by thymoquinone in mice.
Avicenna J. Phytomed. (2016) 6: 55-66.
16) Parvardeh S, Moghimi M, Eslami P and Masoudi A.
α-Terpineol attenuates morphine-induced physical
dependence and tolerance in mice: role of nitric
oxide Iran. J. Basic Med. Sci. (2016) 19: 201-8.
17) Kunnumakkara AB, Bordoloi D, Padmavathi G,
Monisha J, Roy NK, Prasad S and Aggarwal BB.
Curcumin, the golden nutraceutical: multitargeting
for multiple chronic diseases. Br. J. Pharmacol.
(2017) 174: 1325-48.
18) Motaghinejad M, Bangash MY, Hosseini P,
Karimian SM and Motaghinejad O. Attenuation of
morphine withdrawal syndrome by various dosages
of curcumin in comparison with clonidine in mouse:
possible mechanism. Iran. J. Med. Sci. (2015) 40:
19) Motaghinejad M, Karimian M, Motaghinejad O,
Shabab B, Yazdani I and Fatima S. Protective effects
of various dosage of Curcumin against morphine
induced apoptosis and oxidative stress in rat isolated
hippocampus. Pharmacol. Rep. (2015) 67: 230-5.
20) Hu X, Huang F, Szymusiak M, Liu Y and Wang
ZJ. Curcumin attenuates opioid tolerance and
dependence by inhibiting Ca2+/calmodulindependent protein kinase II α activity. J. Pharmacol.
Exp. Ther. (2015) 352: 420-8.
21) Cho JW, Lee KS and Kim CW. Curcumin attenuates
the expression of IL-1β, IL-6, and TNF-α as well as
cyclin E in TNF-α-treated HaCaT cells; NF-κB and
MAPKs as potential upstream targets. Int. J. Mol.
Med. (2007) 19: 469-74.
22) Li Y, Zhang Y, Liu DB, Liu HY, Hou WG and Dong
YS. Curcumin attenuates diabetic neuropathic pain
by downregulating TNF-α in a rat model. Int. J. Med.
Sci. (2013) 10: 377-81.
23) Zhang N, Wei G, Ye J, Yang L, Hong Y, Liu G, Zhong
H and Cai X. Effect of curcumin on acute spinal cord
injury in mice via inhibition of inflammation and
TAK1 pathway. Pharmacol. Rep. (2017) 69: 1001-6.
24) Liu Z, Ran Y, Huang S, Wen S, Zhang W, Liu X,
Ji Z, Geng X, Ji X, Du H and Leak RK. Curcumin
protects against ischemic stroke by titrating
microglia/macrophage polarization. Front. Aging.
Front. Neurosci. (2017) 9: 233.
25) Marghmaleki VS, Alaei HA, Malekabadi HA
and Pilehvarian A. Effect of physical activity on
symptoms of morphine addiction in rats, after and
before of lesion of the mpfc area. Iran. J. Basic Med.
Sci. (2013) 16: 1091-9.
26) Naderi Y, Sabetkasaei M, Parvardeh S and Zanjani
TM. Neuroprotective effect of minocycline on
Sheikholeslami MA et al. / IJPR (2019), 18 (Special Issue): 198-207
cognitive impairments induced by transient cerebral
ischemia/reperfusion through its anti-inflammatory
and anti-oxidant properties in male rat. Brain Res.
Bull. (2017) 131: 207-13.
27) Wang J, Li L, Wang Z, Cui Y, Tan X, Yuan T,
Liu Q, Liu Z and Liu X. Supplementation of
lycopene attenuates lipopolysaccharide-induced
amyloidogenesis and cognitive impairments via
mediating neuroinflammation and oxidative stress.
J. Nutr. Biochem. (2018) 56: 16-25.
28) Ghaemi-Jandabi M, Abdollahi H, Azizi H,
Sadeghizadeh M and Semnanian S. Dendrosomal
curcumin nanoformulation attenuates naloxone
precipitated morphine withdrawal signs in rats. J.
Addiction Res. Ther. (2015) 6: 1-5.
29) Anand P, Kunnumakkara AB, Newman RA and
Aggarwal BB. Bioavailability of curcumin: problems
and promises. Mol. Pharm. (2007) 4: 807-18.
30) Bailey CP and Connor M. Opioids: cellular
mechanisms of tolerance and physical dependence.
Curr. Opin. Pharmacol. (2005) 5:60-8.
31) Ghaemi-Jandabi M, Azizi H, Ahmadi-Soleimani SM
and Semnanian S. Intracoerulear microinjection of
orexin-A induces morphine withdrawal-like signs in
rats. Brain Res. Bull. (2017) 130: 107-11.
32) Ahmadi-Soleimani SM, Azizi H, Gompf HS and
Semnanian S. Role of orexin type-1 receptors
in paragiganto-coerulear modulation of opioid
withdrawal and tolerance: a site specific focus.
Neuropharmacology (2017) 126: 25-37.
33) Zhou W, Liu H and Xie X. The expression of glial
cell derived neurotrophic factor and its receptor
GDNFR-alpha and GDNFR-beta mRNA in spinal
cord, brainstem and frontal cortex during morphine
withdrawal in rats. Zhonghua yi xue za zhi. (2000)
34) Nakajima K and Kohsaka S. Microglia: activation
and their significance in the central nervous system.
J. Biochem. (2001) 130: 169-75.
35) Narita M, Miyatake M, Suzuki M, Kuzumaki N and
Suzuki T. Role of astrocytes in rewarding effects of
drugs of abuse. Nihon shinkei seishin yakurigaku
zasshi= Jpn. J. Psychopharmacol. (2006) 26: 33-9.
36) Daverey A and Agrawal SK. Pre and post treatment
with curcumin and resveratrol protects astrocytes
after oxidative stress. Brain Res. (2018) 1692: 45-55.
37) Sun H, Chen X and Han Z. Effects of curcumin on
the inflammatory reaction induced by LPS and the
expression of SIGIRR in alveolar epithelial cells. J.
Clin. Med. (2017) 33: 1070-3.
38) Su M, Ran Y, He Z, Zhang M, Hu G, Tang W, Zhao D
and Yu S. Inhibition of toll-like receptor 4 alleviates
hyperalgesia induced by acute dural inflammation
in experimental migraine. Mol. Pain (2018) 14:
39) Yang Z, Zhao T, Zou Y, Zhang JH and Feng H.
Curcumin inhibits microglia inflammation and
confers neuroprotection in intracerebral hemorrhage.
Immunol. Lett. (2014) 160: 89-95.
40) Yu Y, Shen Q, Lai Y,Park SY, Ou X, Lin D, Jin M and
Zhang W. Anti-inflammatory effects of curcumin in
microglial cells. Front. Pharmacol. (2018) 9: 386.
41) Chen CY, Kao CL and Liu CM. The cancer
prevention, anti-inflammatory and anti-oxidation
of bioactive phytochemicals targeting the TLR4
signaling pathway. Int. J. Mol. Sci. (2018) 19: 2729